Pan Siwei, Cao Mengxuan, Hu Can, Zhang Yanqiang, Du Yian, Xu Zhiyuan, Cheng Xiangdong
Department of Gastric Surgery, Institute of Cancer Research and Basic Medical Sciences of Chinese Academy of Sciences, Cancer Hospital of University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou 310022, China.
J Oncol. 2023 Jan 28;2023:8629166. doi: 10.1155/2023/8629166. eCollection 2023.
While early gastric cancer (EGC) patients are likely to experience relatively long postoperative survival, certain disease-related findings are associated with a poorer prognosis. This study sought to develop and validate a novel predictive model capable of estimating conditional disease-specific survival (CDSS) in EGC patients.
A total of 3016 patients diagnosed with pT1NxM0 GC after gastrectomy between 1998 and 2016 were selected from the Surveillance, Epidemiology, and End Results (SEER) database and were separated into training and validation cohorts. Kaplan‒Meier curves and log-rank tests were employed to evaluate DSS, after which univariate and multivariate Cox regression analyses were used to construct a predictive nomogram and to estimate CDSS at 1, 2, and 3 years postoperatively in these patients.
In the training cohort, the 3-year CDSS rose from 89.1% to 94.6% from 0 to 5 years postoperatively, while the 5-year CDSS rose from 84.5% to 92.0%. Cox regression analyses led to the construction of a nomogram that was able to reliably predict 3- and 5-year CDSS at 1, 2, and 3 years postoperatively (all < 0.05) based upon patient age, tumor size, pT stage, pN stage, and the number of retrieved lymph nodes. This model exhibited good discriminative power in the training and validation cohorts (concordance index: 0.791 and 0.813, respectively), and nomogram calibration curves confirmed that actual and predicted survival outcomes were close to one another.
We herein developed a nomogram capable of accurately predicting the CDSS of EGC patients that had survived for multiple years after undergoing surgery.
早期胃癌(EGC)患者术后生存期可能相对较长,但某些疾病相关表现与较差的预后相关。本研究旨在开发并验证一种能够估计EGC患者条件性疾病特异性生存期(CDSS)的新型预测模型。
从监测、流行病学和最终结果(SEER)数据库中选取1998年至2016年间接受胃切除术后诊断为pT1NxM0胃癌的3016例患者,并将其分为训练组和验证组。采用Kaplan-Meier曲线和对数秩检验评估疾病特异性生存期(DSS),之后使用单因素和多因素Cox回归分析构建预测列线图,并估计这些患者术后1年、2年和3年的CDSS。
在训练组中,术后3年CDSS从术后0年的89.1%升至5年的94.6%,而5年CDSS从84.5%升至92.0%。Cox回归分析导致构建了一个列线图,该列线图能够根据患者年龄、肿瘤大小、pT分期、pN分期和获取的淋巴结数量,可靠地预测术后1年、2年和3年的3年和5年CDSS(均<0.05)。该模型在训练组和验证组中均表现出良好的区分能力(一致性指数分别为0.791和0.813),列线图校准曲线证实实际生存结果与预测生存结果相近。
我们在此开发了一种能够准确预测EGC患者术后多年生存的CDSS的列线图。